CARM
Carisma Therapeutics, Inc. · NASDAQ
- Sector Health Technology
- Industry Biotechnology
- Website carismatx.com
- Employees(FY) -
- ISIN US14216R1014
Performance
-6.62%
1W
-17.06%
1M
-38.7%
3M
-44.05%
6M
-51.88%
YTD
-71.05%
1Y
Profile
Carisma Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing immunotherapies to treat cancer and other serious diseases. The company's clinical and pre-clinical programs include CT-0508 and CT-0525 targeting HER2 overexpressing tumors; and CT-1119, a CAR-Monocyte for mesothelin overexpressing solid tumors. The company was formerly known as CARMA Therapeutics Inc. and changed its name to Carisma Therapeutics, Inc. in May 2017. The company was founded in 2016 and is headquartered in Philadelphia, Pennsylvania.
Technical Analysis of CARM 2024-05-10
Overview:
In analyzing the technical indicators for CARM stock over the last 5 days, we will delve into the trend, momentum, volatility, and volume indicators to provide a comprehensive outlook on the possible stock price movement in the coming days. By examining these key indicators, we aim to offer valuable insights and predictions for potenti...
Recent News & Updates
- 2024-05-15 19:30
- 2024-05-09 01:54
- 2024-05-08 20:35
- 2024-05-08 19:30
- 2024-05-07 19:30
- 2024-05-05 19:30
- 2024-05-01 22:01
- 2024-05-01 19:30
- 2024-04-24 05:05
- 2024-04-22 04:35
- 2024-04-03 21:55
- 2024-04-02 19:00
- 2024-04-01 01:53
- 2024-03-31 20:35
- 2024-03-31 19:00
- 2024-03-21 05:00
- 2024-02-27 18:30
- 2023-12-20 18:00
- 2023-12-13 18:00
- 2023-11-27 18:00
- 2023-11-21 18:30
- 2023-11-08 18:30
- 2023-10-30 21:25
- 2023-10-24 21:11
- 2023-10-12 02:52
3 Top Under-$5 Stocks for Strong Gains and Positive Outlook(Yahoo Finance)
- 2023-09-04 20:30
- 2023-08-31 20:30
- 2023-08-23 20:30
- 2023-08-22 21:55
- 2023-08-12 20:07
Page 1 of 2
previousnext